Hyperactivation of the epidermal growth factor receptor (EGFR) signaling pathway, often due to gene amplification, and inactivation of the PTEN tumor suppressor gene are the main drivers of the aggressive phenotype of high-grade gliomas [10,11,12]. The gene discussed is EGFR; the disease is glioma.